舍曲林联合喹硫平治疗难治性强迫症临床随机对照研究(2)
第1页 |
参见附件。
参 考 文 献
[1] 钱志梅,王曙光,张苏静.氯米帕明联合阿立哌唑治疗难治性强迫症的增效作用.临床精神医学杂志,2009,19(6):387-88.
[2] Kordon A, Wahl K, Koch N, et al. Quetiapine addition to serotonin reuptake inhibitors in patients with severe obsessive-compulsive disorder:a double-blind, randomized, placebo- controlled study. J Clin Psychopharmaco,l 2008, 28:550-554.
[3] Atmaca M, Kuloglu M, Tezcan E, et al. Quetiapine augmentation in patients with treatment resistant obsessive-compulsive disorder:a single-blind, placebo-controlled study. IntClin Psychopharmacol, 2002, 17:115-119.
[4] 崔永华,仲崇丽. 舍曲林合并奎硫平治疗难治性强迫症对照研究.临床精神医学杂志,2009,19(4):270-271.
[5] 范肖冬,汪向东,于欣,等译.世界卫生组织.ICD-10精神与行为障碍分类临床描述与诊断要点.北京:人民卫生出版社, 1993:116-118.
[6] 张一,孟凡强, 崔玉华, 等.修改耶鲁-希郎强迫量表的临床信度和效度研究.中国心理卫生杂志,1996,10 (5):205-207.
[7] 汤毓华.汉密顿焦虑量表(HamiltonAnxiety Scale,HAMA).中国心理卫生杂志,1993,(增刊):253-255.
[8] 刘增龙,崔利军,周会爽,等.难治性精神分裂症临床分析.河北医药,2010,32(3):3256-3257.
[9] Denys D, deGeus F, van Megen HJ, et al. A double-blind, random-ized, placebo-controlled trialof quetiapineaddition in patients with obsessive-compulsive disorder refractory to serotonin reuptake in-hibitors ......
您现在查看是摘要介绍页,详见PDF附件(4298kb)。